Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Pokhrel, Ram Hari ^a   Thapa, Badri ^b,c   Kafle, Rajesh ^a   Shah, Pradeep Kumar ^a   Tribuddharat, Chanwit ^d  

^a St Xavier's College   (Nepal)

^b KATHMANDU MEDICAL COLLEGE   (Nepal)

^c Genesis Laboratory and Research   (Nepal)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Carbapenemases; Clinical isolates; ESBL producing Escherichia coli; Integron element

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEPAL; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENOTYPE; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; NEPAL;

EID: 84907931036     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-694     Document Type: Article

References (29)

1. Complicated catheter- associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME, Clin Microbiol Rev 2008 21 1 26 59 10.1128/CMR.00019-07 18202436
2. Surgical site infections: a one year prospective study in a tertiary care centre. Shahane V, Bhawal S, Lele U, Int J Health Sci 2012 6 1 79 84
3. Recurrent infections and chronic colonization by an Escherichia coli clone in the respiratory tract of a patient with severe cystic bronchiectasis. Wang JY, Hsueh PR, Wang JT, Lee LN, Yang PC, Luh KT, J Clin Microbiol 2000 38 7 2766 2767 10878083
4. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials-catheters, ventilator-associated pneumonia, urinary tract infections. Guggenbichler JP, Assadian O, Boeswald M, Kramer A, GMS Krankenhhyg Interdis Zip 2011 6 1 oc 18
5. Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study. Meybeck A, Ricard JD, Barnaud G, Eveillard M, Chevrel G, Mounier R, Dreyfuss D, BMC Infect Dis 2008 8 67 10.1186/1471-2334-8-67 18485230
6. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. Chander A, Shrestha CD, BMC Res Notes 2013 6 487 10.1186/1756-0500-6-487 24274894
7. Extended-spectrum beta-lactamases in gram negative bacteria. Rawat D, Nair D, J Glob Infect Dis 2010 2 3 263 274 10.4103/0974-777X.68531 20927289
8. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Pitout JD, Laupland KB, Lancet Infect Dis 2008 8 3 159 166 10.1016/S1473-3099(08)70041-0 18291338
9. High prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Nepal. Hammar DA, Dangol S, Anderson TP, Wong JSJ, Werno AM, Murdoch DR, Int J Antimicrob Agents 2007 30 5 471 472 10.1016/j.ijantimicag.2007.07.004 17851048
10. Tests for identification of bacteria. Collee JG, Miles RS, Watt B, Mackie and McCartney Practical Medical Microbiology New York: Churchill Livingstone, Collee JG, Fraser AG, Marmion BP, Simmons A, 14 1996 131 149
11. Clinical Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement (M 100-S21) Wayne PA: Clinical and Laboratory Standards Institute 2011
12. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults. Pongpech P, Naenna P, Taipobsakul Y, Tribuddharat C, Srifuengfung S, Southeast Asian J Trop Med Public Health 2008 39 3 425 433 18564681
13. High prevalence of bla (OXA)-23 in oligoclonal carbapenem-resistant Acinetobacter baumannii from Siriraj Hospital, Mahidol University, Bangkok, Thailand. Thapa B, Tribuddharat C, Srifuengfung S, Dhiraputra C, Southeast Asian J Trop Med Public Health 2010 41 3 625 635 20578551
14. How to detect the NDM-1 producers. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR, J Clin Microbiol 2011 49 2 718 721 10.1128/JCM.01773-10 21123531
15. The rising problem of antimicrobial resistance in the intensive care unit. Brusselaers N, Vogelaers D, Blot S, Ann Intensive Care 2011 1 47 10.1186/2110-5820-1-47 22112929
16. ESBLs: a clear and present danger. Dhillon RHP, Clark J, Crit Care Res Prac 2012 2012 625170
17. Emergence of high levels of extended-spectrum-lactamase-producing gram-negative bacilli in the Asia-Pacific Region: data from the study for monitoring antimicrobial resistance trends (SMART) program, 2007. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL, Antimicrob Agents Chemother 2009 53 8 3280 3284 10.1128/AAC.00426-09 19506060
18. Infections with extended-spectrum β-lactamase-producing Enterobacteriaceae. Jahan DD, Pitout JD, Drugs 2010 70 3 313 333 10.2165/11533040-000000000-00000 20166768
19. Detection of CTX-M-type extended spectrum beta-lactamase (ESBLs) by testing with microscan overnight and ESBL confirmation panels. Jorgensen JH, Mc Elmeel ML, Fulcher LC, Zimmer BL, J Clin Microbial 2010 48 1 120 123 10.1128/JCM.01507-09
20. Dissemination of multiple drug resistance genes by class 1 integrons in Klebsiella pneumonia isolates from four countries: a comparative study. Chowdhury PR, Ingold A, Vanegas N, Martinez E, Merlino J, Merkier AK, Castro M, Rocha G, Borthagaray G, Centron D, Toledo HB, Morquez CM, Stokes HW, Antimicrob Agents Chemother 2011 55 7 3140 3149 10.1128/AAC.01529-10 21518841
21. Prevalence of ESBL, AmpC and carbapenemase among Gram negative bacilli isolated from clinical specimens. Doddaiah V, Anjaneya D, Am J Life Sci 2014 2 2 76 81 10.11648/j.ajls.20140202.17
22. Extended-spectrum ß-Lactamases (ESBLs): a global problem. Al-Jasser AM, Kuwait Med J 2006 38 3 171 185
23. Characterization and sequence analysis of extended-spectrum lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during Tigecycline Phase 3 clinical trials. Jones TH, Tuckman M, Keeney D, Ruzin A, Bradford PA, Antimicrob Agents Chemother 2008 53 2 465 475 19015360
24. Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum beta-lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Bali EB, Acik L, Sultan N, Afr J Microbiol Res 2010 4 8 650 654
25. Detection of beta-lactamase producing bacterial genes and their clinical features. Hasim RB, Husin S, Rahman MM, Pak J Biol Sci 2011 14 1 41 46 21913496
26. The CTX-M beta-lactamase pandemic. Canton R, Coque TM, Curr Opin Microbiol 2006 9 5 466 475 10.1016/j.mib.2006.08.011 16942899
27. Genotypic detection and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. Lin CF, Hsu SK, Chen CH, Huang JR, Lo HH, J Med Microbiol 2010 59 6 665 671 10.1099/jmm.0.015818-0 20150317
28. Dissemination of CTX-M-Type β-Lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Eckert C, Gautier V, Antimicrob Agents Chemother 2004 48 4 1249 1255 10.1128/AAC.48.4.1249-1255.2004 15047527
29. Dissemination of multidrug-resistant Klebsiella pneumoniae clinical isolates with various combinations of carbapenemases (NDM-1 and OXA-72) and 16S rRNA methylases (ArmA, RmtC and RmtF) in Nepal. Tada T, Miyoshi-Akiyama T, Dahal RK, Mishra SK, Ohara H, Shimada K, Kirikae T, Pokhrel BM, Int J Antimicrob Agents 2013 42 4 372 374 10.1016/j.ijantimicag.2013.06.014 23978353